Podcast: A new paradigm for generative AI drug discovery

Archetype CEO Tom Neyarapally spoke with Rafael Rosengarten, CEO of Genialis and host of Talking Precision Podcast (TPM) about Archetype’s patient-first approach to drug discovery. Key topics include the use of generative AI to model drug-disease-outcome relationships, moving beyond target-based drug design to focus on modulating biological pathways more broadly, validating predictions through real-world studies, and the greater vision of building a biotech company that adapts to patient needs and advances precision medicine.

Listen to the podcast episode below.